Jones Financial Companies Lllp Raises Holdings in Solventum Corporation $SOLV

Key Points

• Jones Financial Companies Lllp significantly increased its holdings in Solventum Corporation by 3,484.6% during the first quarter, now owning approximately 120,656 shares valued at $9.18 million.
• Several large investors, including Rossby Financial and Strengthening Families & Communities, also made substantial changes to their positions in Solventum during the first quarter.
• Recent analyst reports have favorably impacted SOLV's stock, with price targets raised by firms like Morgan Stanley and Wells Fargo, reflecting a growing optimism about the company.

Jones Financial Companies Lllp boosted its stake in shares of Solventum Corporation (NYSE:SOLV - Free Report) by 3,484.6% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 120,656 shares of the company's stock after purchasing an additional 117,290 shares during the quarter. Jones Financial Companies Lllp owned approximately 0.07% of Solventum worth $9,175,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Rossby Financial LCC purchased a new stake in Solventum during the 1st quarter worth about $25,000. Strengthening Families & Communities LLC boosted its position in shares of Solventum by 376.8% during the 1st quarter. Strengthening Families & Communities LLC now owns 329 shares of the company's stock worth $25,000 after acquiring an additional 260 shares in the last quarter. Raiffeisen Bank International AG acquired a new position in shares of Solventum during the 4th quarter worth about $29,000. Hara Capital LLC acquired a new position in shares of Solventum during the 1st quarter worth about $38,000. Finally, Smartleaf Asset Management LLC boosted its position in shares of Solventum by 193.4% during the 1st quarter. Smartleaf Asset Management LLC now owns 534 shares of the company's stock worth $40,000 after acquiring an additional 352 shares in the last quarter.

Analyst Ratings Changes

Several research analysts have recently issued reports on SOLV shares. KeyCorp started coverage on Solventum in a research report on Friday, June 6th. They set a "sector weight" rating for the company. Jefferies Financial Group started coverage on Solventum in a research report on Thursday. They set a "hold" rating and a $80.00 price objective for the company. Argus raised Solventum from a "hold" rating to a "buy" rating and set a $90.00 price objective for the company in a research report on Tuesday, July 1st. Wall Street Zen cut Solventum from a "strong-buy" rating to a "buy" rating in a research report on Tuesday. Finally, Morgan Stanley raised Solventum from an "equal weight" rating to an "overweight" rating and upped their price objective for the stock from $80.00 to $103.00 in a research report on Tuesday, July 15th. Four analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $85.11.

Solventum Stock Performance

Solventum stock traded down $0.47 during mid-day trading on Friday, reaching $73.32. 1,572,374 shares of the company were exchanged, compared to its average volume of 1,081,112. Solventum Corporation has a twelve month low of $60.70 and a twelve month high of $85.92. The firm's 50-day simple moving average is $73.18 and its two-hundred day simple moving average is $72.73. The company has a debt-to-equity ratio of 2.14, a quick ratio of 0.86 and a current ratio of 1.22. The firm has a market cap of $12.71 billion, a PE ratio of 33.95, a price-to-earnings-growth ratio of 2.91 and a beta of 0.53.

Solventum (NYSE:SOLV - Get Free Report) last issued its earnings results on Thursday, August 7th. The company reported $1.69 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.45 by $0.24. The business had revenue of $2.16 billion during the quarter, compared to the consensus estimate of $2.12 billion. Solventum had a return on equity of 29.93% and a net margin of 4.52%.The company's revenue for the quarter was up 3.8% on a year-over-year basis. During the same period in the prior year, the business posted $1.56 EPS. Solventum has set its FY 2025 guidance at 5.800-5.950 EPS. Equities analysts predict that Solventum Corporation will post 6.58 earnings per share for the current fiscal year.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.